Discovery of novel virus neutralizing antibodies
The identification of novel antibodies to neutralize the virus is one of our approaches to fight COVID-19. In particular, we aim to discover an antibody against the SARS-CoV-2 spike protein by building on knowledge about the existing structure of SARS-CoV-2 and learnings from previous SARS antibody generations. The so-called spike protein of 2019-nCoV is used by the virus to dock to human cells. By targeting the protein, we aim to prevent the infection.